UnitedHealth Q1 EPS $6.90; FY guidance raised; Alegeus deal, $2B buyback

UNITEDHEALTH GROUP INC

2026-Q1 EPS reported $6.90 vs consensus $6.64 ▲ beat (+3.9%)

Q1 revenues $111.7B (+2% YoY); GAAP EPS $6.90, adjusted $7.23.
Medical cost ratio improved 90 bps to 83.9%; operating cost ratio up to 13.8%.
FY2026 guidance raised: GAAP EPS >$17.35, adjusted >$18.25.
Agreed to acquire Alegeus Technologies (earnings neutral, close H2 2026).
At least $2B stock buyback expected by end of Q2 2026; Optum UK sale netted $400M.

item 2.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.9

UNITEDHEALTH GROUP INC reported first quarter 2026 results: revenue $111.7 billion, EPS $6.90 per share. Guidance raised.

Period: first quarter 2026
Revenue: $111.7 billion
EPS: $6.90 per share
Guidance: raised
Result: reported results

Exact text from the filing

UnitedHealth Group Reports First Quarter 2026 Results • First Quarter 2026 Revenues of $111.7 Billion Grew 2% Year-over-Year • Earnings of $6.90 Per Share and Adjusted Earnings of $7.23 Per Share • Full Year 2026 Earnings Outlook Raised to Greater Than $17.35 Per Share; Adjusted Earnings of Greater Than $18.25 Per Share

View on SEC.gov

1341 earnings releases filed in the last 30 days. Browse all earnings releases →

UNITEDHEALTH GROUP INC filing history →

Source: SEC EDGAR

accession 0000731766-26-000121

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.